Portfolio of UGA Startups

The Innovation Gateway incubator聽is intended for startup or early-stage companies that are involved in the research and development of new products and services.

Companies must have established research relationships with 香港管家婆资料免费大全 researchers, or they must have an interest in initiating those relationships.聽Priority consideration will be given to those companies who have a technology licensing agreement with the 香港管家婆资料免费大全 Research Foundation.

These companies meet Innovation Gateway聽admission criteria: industry application, market opportunity, financial status, management experience, intellectual property, relationship to UGA and job creation.

CompanyCEO or Company RepresentativeDescription
Steve SticeCommercializing products and services derived from or related to human stem cells.
Yajun YanBiotecEra is manufacturing specialty chemicals and nutritional supplements such as the anti-depressant, 5-HTP using modern biotechnological techniques.
Ron OrlandoCommercializing reagents for mass spec-based carbohydrate analysis.
Lori YangLectenz Bio is developing novel products that employ patent pending Lectenz庐 reagents and GlycoSense鈩 technology, to speed up and simplify the detection and discovery of disease biomarkers. These products enable targeting glycan biomarkers of clinical significance for investigation and leveraging them for advancing human health.
Joe GrubbsCommercializing sustainable, renewable bioplastic technologies for global customers.
Molecular TherapeuticsBran RitchieManufacturing Silvion庐 and Silvaklenz庐, solutions proven to kill most pathogenic bacteria.
Valentine NzengungProvides a range of environmental remediation services and sustainable green technologies.
CyanVacBiao HeA vaccine development company advancing the use of ParaInfluenza 5 (PIV-5) as a vaccine platform for the prevention of both animal and human infectious diseases.
Fred QuinnCommercializing discoveries made in the field of vaccination, including a cold-adapted bacterium that can provide a platform technology for the production of a wide range of vaccines or vaccine vectors.
Erico MattosReducing production costs for greenhouse growers by helping them implement more cost-effective supplemental lighting strategies.
Xiaozhong (John) YuDeveloping in vitro mini testis for the performance of toxicity testing on reproductive tissue.
Ivana Gelineo-AlbersheimProduces novel enzymes derived from extremophilic microorganisms that are more stable and effective than alternatives when used in challenging industrial settings.
ViamuneAlex HarveyViaMune is a preclinical-stage company with a proprietary immunotherapy platform that enables precise targeting of tumor associated glycopeptides.
Suren ChavanDeveloping a cure for insulin dependent diabetes. ViCapsys' lead clinical candidate has demonstrated efficacy mitigating immune response and foreign body recognition, rendering encapsulated islet transplantation a viable solution.

Although affiliate聽companies do not meet residency criteria, they聽have a substantive relationship to UGA through intellectual property, sponsored research, and faculty participation.

Tom StriblingCommercializing software that provides a rapid and accurate physicochemical property calculator to the chemical and pharmaceutical market.
Carsten HellmannCommercializing animal pharmaceutical products, vaccines and services for health and well-being of companion animals (dogs, cats and horses), production animals (cattle, poultry, swine), and wildlife. Global operations include facilities located at UGA, which develop collaborative opportunities with UGA scientists.
Paul MontelloProvides low-temperature backup and archiving services to academic, corporate and government research laboratories.
Massoud AlibakhshProvides health IT tools for the efficient management of physician practices.
Stephen BellProventus Bio is a recently formed biotechnology company focused on enhancing bioproduction through genetic engineering of vaccine and biotherapeutic cell lines.
Allan RobinsA regenerative medicine company commercializing cell therapies to treat diabetes. Headquartered in San Diego.
Jenna JambeckProvides a platform to facilitate communication about waste between citizens and their community through a聽community-built map of outdoor and event trash cans and recycle bins and a mobile app.

Companies are eligible for graduation from Innovation Gateway聽when established revenue, financing, management, facilities or production milestones are achieved.

Richard ShimketsDeveloping a technology that greatly enhances the speed and efficiency of monoclonal antibody discovery and production.
Mike Van DrunenDeveloping algal bioplastics using a protein-based thermomechanical approach. These protein based bioplastics exhibit superior biodegradability to existing bioplastics.
ApgenDavid GlassApplied PhytoGenetics, Inc. utilizes plants, trees and grasses to remove or degrade hazardous materials from the environment through phytoremediation.
Bacterial BarcodesAcquired by BioM茅rieux (2006)Commercializes DiversiLab, a patented system of automated microbial genotyping offering solutions to track hospital-acquired infections.
BioInquireAquired by (2010)Develops software solutions for proteomic data-mining applications.
Body Surface TranslationsGregg BeVierDeveloping a handheld device capable of remotely and accurately assessing the weight of an animal. Currently marketed to pork producers.
Tom RobertsonDevelops inquiry-based 3-D educational materials that increase high school student performance and interest in science and technology.
P3 LaboratoriesJeffrey H. PingProvides consulting, development, production, and post-marketing technical support to the pharmaceutical industry for the development of niche products.
Neelam DattaProvides a range of research products and services, with a focus on products for Alzheimer's and Parkinson's research. Their beta amyloids, synucleins and taus are produced recombinantly, ensuring a high degree of batch-to-batch reproducibility.
Synageva BiopharmaDiscovers, develops and delivers medicines for patients with rare disease and high unmet medical need.
ViaGenAcquired by ProLinia (2003)Identifies economically important genetic traits in any animal species and applies them to commercial breeding operations.
Hardy EdwardsManufactures 1-OH-Vitamin D3 for the global poultry industry. This particular D3 derivative is the most bioactive on the market, preventing fibial dyschoncroplasia.